These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6517542

  • 1. Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coli.
    Hof H, Rieffert M, Sticht-Groh V, Zak O, Schweizer EH.
    Antimicrob Agents Chemother; 1984 Oct; 26(4):498-500. PubMed ID: 6517542
    [Abstract] [Full Text] [Related]

  • 2. Antibacterial effects of niridazole: its effect on microaerophilic campylobacter.
    Hof H, Sticht-Groh V.
    Infection; 1984 Oct; 12(1):36-9. PubMed ID: 6706411
    [Abstract] [Full Text] [Related]

  • 3. Effect of different nitroheterocyclic compounds on aerobic, microaerophilic, and anaerobic bacteria.
    Hof H, Ströder J, Buisson JP, Royer R.
    Antimicrob Agents Chemother; 1986 Nov; 30(5):679-83. PubMed ID: 3800344
    [Abstract] [Full Text] [Related]

  • 4. Antibacterial activities of nitrothiazole derivatives.
    Hof H, Zak O, Schweizer E, Denzler A.
    J Antimicrob Chemother; 1984 Jul; 14(1):31-9. PubMed ID: 6384174
    [Abstract] [Full Text] [Related]

  • 5. Antibacterial activity of GO 10213, a nitroimidazole derivative.
    Hof H, Ströder J.
    Antimicrob Agents Chemother; 1986 May; 29(5):953-4. PubMed ID: 3729357
    [Abstract] [Full Text] [Related]

  • 6. Susceptibility of Campylobacter species to metronidazole, its bioactive metabolites and tinidazole.
    Bannatyne RM, Jackowski J, Karmali MA.
    Infection; 1987 May; 15(6):457-8. PubMed ID: 3436679
    [Abstract] [Full Text] [Related]

  • 7. In vitro susceptibilities of 40 Campylobacter fetus subsp. jejuni strains to niridazole and metronidazole.
    Freydière AM, Gille Y, Tigaud S, Vincent P.
    Antimicrob Agents Chemother; 1984 Jan; 25(1):145-6. PubMed ID: 6703680
    [Abstract] [Full Text] [Related]

  • 8. Susceptibility of Campylobacter species to niridazole.
    Bannatyne RM, Karmali MA, Jackowski J, Roscoe M.
    Eur J Clin Microbiol; 1986 Dec; 5(6):664-5. PubMed ID: 3803380
    [No Abstract] [Full Text] [Related]

  • 9. Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria.
    Hof H, Sticht-Groh V, Müller KM.
    Antimicrob Agents Chemother; 1982 Aug; 22(2):332-3. PubMed ID: 6927288
    [Abstract] [Full Text] [Related]

  • 10. Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents.
    Walder M.
    Antimicrob Agents Chemother; 1979 Jul; 16(1):37-9. PubMed ID: 475372
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.
    Vanhoof R, Vanderlinden MP, Dierickx R, Lauwers S, Yourassowsky E, Butzler JP.
    Antimicrob Agents Chemother; 1978 Oct; 14(4):553-6. PubMed ID: 718153
    [Abstract] [Full Text] [Related]

  • 12. Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni.
    Vanhoof R, Gordts B, Dierickx R, Coignau H, Butzler JP.
    Antimicrob Agents Chemother; 1980 Jul; 18(1):118-21. PubMed ID: 7416738
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility of clinical isolates of Campylobacter jejuni to sixteen antimicrobial agents.
    Michel J, Rogol M, Dickman D.
    Antimicrob Agents Chemother; 1983 May; 23(5):796-7. PubMed ID: 6870228
    [Abstract] [Full Text] [Related]

  • 14. In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Denmark to fourteen antimicrobial agents.
    Andreasen JJ.
    Acta Pathol Microbiol Immunol Scand B; 1987 Jun; 95(3):189-92. PubMed ID: 3630712
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the in vitro activity of nifuroxazide on enteropathogenic microorganisms: determination of bacteriostatic and bactericidal concentrations and disk susceptibility.
    Vanhoof R, Coignau H, Stas G, Butzler JP.
    Acta Clin Belg; 1981 Jun; 36(3):126-9. PubMed ID: 7270001
    [No Abstract] [Full Text] [Related]

  • 16. [Examination of the antibacterial action of metronidazole against vibrios and Campylobacter (author's transl)].
    Füzi M.
    Zentralbl Bakteriol A; 1981 Jun; 249(2):242-6. PubMed ID: 7269853
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates.
    Karmali MA, De Grandis S, Fleming PC.
    Antimicrob Agents Chemother; 1981 Apr; 19(4):593-7. PubMed ID: 7247381
    [Abstract] [Full Text] [Related]

  • 18. Mutagen screening with bacteria: niridazole and nitrofurans.
    McCalla DR, Voutsinos D, Olive PL.
    Mutat Res; 1975 Feb; 31(1):31-7. PubMed ID: 1093013
    [Abstract] [Full Text] [Related]

  • 19. In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents.
    Ahonkhai VI, Cherubin CE, Sierra MF, Bokkenheuser VD, Shulman MA, Mosenthal AC.
    Antimicrob Agents Chemother; 1981 Dec; 20(6):850-1. PubMed ID: 6459767
    [Abstract] [Full Text] [Related]

  • 20. Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli.
    Wang WL, Reller LB, Blaser MJ.
    Antimicrob Agents Chemother; 1984 Sep; 26(3):351-3. PubMed ID: 6508265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.